ROP vs TMCI · P/E 41, rev $4.20B vs rev $92.6M
Roper Technologies, Inc. (ROP) versus Treace Medical Concepts Inc (TMCI) — a side-by-side from cached financials, not a winner call.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Treace Medical Concepts Inc (TMCI) is a medical devices company listed on NASDAQ.
Latest reported ROP revenue for 2026-06-30 was $4.20B. Net income was $1.68B. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Latest reported TMCI revenue for 2026-06-30 was $92.6M. Net income was -$33.8M. Revenue was up 96.1% from 2026-03-31 to 2026-06-30. TMCI currently screens at market cap $260.1M.
ROP currently screens at market cap $61.61B and trailing P/E 41.3. TMCI currently screens at market cap $260.1M.
Not investment advice. Open the ROP and TMCI stock pages for the full models.
Not investment advice.